David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
PUT
Huntsman Corp
HUN
$1.68B
| $304K | ﹤0.01% |
+11,100
| New | +$296K |
|
|
RAD
3102
DELISTED
Rite Aid Corporation
RAD
| $303K | ﹤0.01% |
7,738
-412
| -5% | -$19.5K |
|
|
ESV
3103
DELISTED
Ensco Rowan plc
ESV
| $301K | ﹤0.01% |
12,600
-884,753
| -99% | -$17.7M |
|
3104
Forestar Group
FOR
$1.47B
| $300K | ﹤0.01% |
+17,434
| New | +$300K |
|
|
VRN
3105
DELISTED
Veren
VRN
| $300K | ﹤0.01% |
37,321
-3,243
| -8% | -$23.7K |
|
3106
PENN Entertainment
PENN
$2.45B
| $299K | ﹤0.01% |
+12,786
| New | +$274K |
|
|
HZNP
3107
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $299K | ﹤0.01% |
+23,594
| New | +$300K |
|
3108
First Commonwealth Financial
FCF
$2.12B
| $298K | ﹤0.01% |
+21,100
| New | +$272K |
|
|
LHCG
3109
CALL
DELISTED
LHC Group LLC
LHCG
| $298K | ﹤0.01% |
4,200
| – | – |
|
|
IMOS
3110
ChipMOS TECHNOLOGIES
IMOS
$1.89B
| $297K | ﹤0.01% |
13,054
-49,376
| -79% | -$1.09M |
|
3111
Navigator Holdings
NVGS
$1.37B
| $297K | ﹤0.01% |
+26,771
| New | +$277K |
|
|
LCI
3112
DELISTED
Lannett Company, Inc.
LCI
| $297K | ﹤0.01% |
+4,027
| New | +$296K |
|
3113
National Healthcare
NHC
$3.58B
| $296K | ﹤0.01% |
+4,726
| New | +$305K |
|
3114
Booz Allen Hamilton
BAH
$9.05B
| $292K | ﹤0.01% |
7,817
-22,895
| -75% | -$787K |
|
3115
Gladstone Investment Corp
GAIN
$657M
| $292K | ﹤0.01% |
+30,738
| New | +$289K |
|
|
DCOM
3116
DELISTED
Dime Community Bancshares
DCOM
| $292K | ﹤0.01% |
13,571
-4,151
| -23% | -$81.8K |
|
3117
City Holding Co
CHCO
$2.04B
| $291K | ﹤0.01% |
4,044
-4,967
| -55% | -$322K |
|
3118
Extra Space Storage
EXR
$30.9B
| $291K | ﹤0.01% |
+3,640
| New | +$283K |
|
3119
STAAR Surgical
STAA
$1.17B
| $291K | ﹤0.01% |
23,410
-3,383
| -13% | -$37.7K |
|
|
IMMU
3120
DELISTED
Immunomedics Inc
IMMU
| $291K | ﹤0.01% |
+20,791
| New | +$207K |
|
|
PFNX
3121
DELISTED
Pfenex Inc.
PFNX
| $291K | ﹤0.01% |
96,454
+7,549
| +8% | +$28.7K |
|
|
HES
3122
DELISTED
Hess
HES
| $289K | ﹤0.01% |
6,174
-96,895
| -94% | -$4.1M |
|
|
PVG
3123
DELISTED
PRETIUM RESOURCES INC.
PVG
| $289K | ﹤0.01% |
31,163
+7,793
| +33% | +$69.9K |
|
3124
Winmark
WINA
$1.26B
| $288K | ﹤0.01% |
2,189
-891
| -29% | -$117K |
|
|
BSFT
3125
DELISTED
BroadSoft, Inc.
BSFT
| $288K | ﹤0.01% |
+5,730
| New | +$262K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.